Forward Pharma A/S American Depositary Shares
FWP was delisted on the 27th of December, 2022.
8 hedge funds and large institutions have $4.45M invested in Forward Pharma A/S American Depositary Shares in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 5 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
14% more funds holding
Funds holding: 7 → 8 (+1)
2% more capital invested
Capital invested by funds: $4.36M → $4.45M (+$85K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MCM
Mason Capital Management
New York
|
+$330K |
| 2 |
Citigroup
New York
|
+$17.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$95.4K |
| 2 |
Morgan Stanley
New York
|
-$27.2K |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$12.8K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$7K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$6.87K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BI
1
BVF Inc
San Francisco,
California
| $2.52M | – | – | – |
|
|
2
Morgan Stanley
New York
| $1.07M | -$27.2K | -4,881 | -3% |
|
|
3
Acadian Asset Management
Boston,
Massachusetts
| $356K | -$12.8K | -2,303 | -4% |
|
|
MCM
4
Mason Capital Management
New York
| $344K | +$330K | +59,141 | New |
|
|
5
Renaissance Technologies
New York
| $142K | -$95.4K | -17,100 | -41% |
|
|
6
Citigroup
New York
| $19K | +$17.8K | +3,187 | New |
|
7
Osaic Holdings
Scottsdale,
Arizona
| $6K | -$5.58K | -1,000 | -50% |
|
|
8
UBS Group
Zurich,
Switzerland
| – | -$7K | -1,236 | Closed |
|
|
9
Bank of America
Charlotte,
North Carolina
| – | -$6.87K | -1,231 | -95% |
|
FWP Hedge Fund Activity: Q1 2022 in Review
8 of the 6,340 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q1 2022, worth a combined $4.45M — up 1.9% from $4.36M a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new FWP positions and 1 closed out — a net gain of 1 holder — while 0 added to existing stakes and 5 trimmed.
The largest buyer was Mason Capital Management, opening a new position worth an estimated $330K. The largest seller was Renaissance Technologies, cutting an estimated $95.4K.
- 8 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q1 2022, up from 7 in Q4 2021.
- Funds reported $4.45M of Forward Pharma A/S American Depositary Shares stock for Q1 2022, up 1.9% quarter-over-quarter.
- 2 funds opened new Forward Pharma A/S American Depositary Shares positions in Q1 2022 and 1 closed out, a net change of +1 holder.
- The largest Forward Pharma A/S American Depositary Shares buyer in Q1 2022 was Mason Capital Management, an estimated $330K added.
- The largest Forward Pharma A/S American Depositary Shares seller in Q1 2022 was Renaissance Technologies, an estimated $95.4K sold.
Based on aggregated 13F filings for Q1 2022.